Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Genome Research Limited
Genome Research Limited is an active company incorporated on 20 August 1992 with the registered office located in Saffron Walden, Cambridgeshire. Genome Research Limited was registered 33 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
02742969
Private limited by guarantee without share capital
Age
33 years
Incorporated
20 August 1992
Size
Large
Turnover is over
£54M
Balance sheet is over
£27M
Over
250 employees
Confirmation
Submitted
Dated
23 June 2025
(2 months ago)
Next confirmation dated
23 June 2026
Due by
7 July 2026
(10 months remaining)
No changes
occurred since incorporation
Accounts
Submitted
For period
1 Oct
⟶
30 Sep 2024
(1 year)
Accounts type is
Full
Next accounts for period
30 September 2025
Due by
30 June 2026
(9 months remaining)
Learn more about Genome Research Limited
Contact
Address
Wellcome Sanger Institute Wellcome Genome Campus
Hinxton
Saffron Walden
CB10 1SA
England
Address changed on
10 May 2023
(2 years 3 months ago)
Previous address was
Gibbs Building 215 Euston Road London NW1 2BE England
Companies in CB10 1SA
Telephone
01223834244
Email
Available in Endole App
Website
Sanger.ac.uk
See All Contacts
People
Officers
12
Shareholders
-
Controllers (PSC)
1
Dr Nicole Mather
Director • Management Consultant • British • Lives in England • Born in Aug 1974
Dr Daniel Mahony
Director • Investment Professional • British • Lives in England • Born in Mar 1969
Mark McCarthy
Director • Non Executive Director • British • Lives in United States • Born in Jul 1960
Dr John-Arne RØttingen
Director • Non Executive Director • Norwegian • Lives in England • Born in Mar 1969
Dr Paul Jakob Robert Schreier
Director • Chief Operating Officer • British,australian • Lives in England • Born in Jan 1969
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Simplyhealth Access
Dr Paul Jakob Robert Schreier is a mutual person.
Active
Kidney Research UK
Mr Matthew Newcombe-Ellis is a mutual person.
Active
Bioindustry Association
Dr Daniel Mahony is a mutual person.
Active
Denplan Limited
Dr Paul Jakob Robert Schreier is a mutual person.
Active
The Wellcome Trust Limited
Dame Cilla Snowball is a mutual person.
Active
Kidney Research Enterprises Limited
Mr Matthew Newcombe-Ellis is a mutual person.
Active
Simplyhealth Funding Services Limited
Dr Paul Jakob Robert Schreier is a mutual person.
Active
Simplyhealth Group Limited
Dr Paul Jakob Robert Schreier is a mutual person.
Active
See All Mutual Companies
Brands
Wellcome Genome Campus
The Wellcome Genome Campus is a research institute focused on genome and biodata research.
Wellcome Sanger Institute
The Wellcome Sanger Institute is a genomics research institute located in Cambridge.
Hinxton Hall Conference Centre
Hinxton Hall Conference Centre provides conference and meeting facilities within a Grade II* listed country house located in a parkland estate.
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
30 Sep 2024
For period
30 Sep
⟶
30 Sep 2024
Traded for
12 months
Cash in Bank
£15.36M
Increased by £1.55M (+11%)
Turnover
£177.35M
Decreased by £11.68M (-6%)
Employees
1.3K
Increased by 87 (+7%)
Total Assets
£357.36M
Increased by £9.97M (+3%)
Total Liabilities
-£87.12M
Increased by £11.29M (+15%)
Net Assets
£270.24M
Decreased by £1.32M (-0%)
Debt Ratio (%)
24%
Increased by 2.55% (+12%)
See 10 Year Full Financials
Latest Activity
Confirmation Submitted
2 Months Ago on 23 Jun 2025
Daniel Mahony Resigned
4 Months Ago on 2 May 2025
Full Accounts Submitted
7 Months Ago on 9 Jan 2025
Cilla Snowball Resigned
1 Year 1 Month Ago on 18 Jul 2024
Confirmation Submitted
1 Year 1 Month Ago on 11 Jul 2024
Paul Jakob Robert Schreier Resigned
1 Year 3 Months Ago on 1 Jun 2024
Dr John-Arne Røttingen Appointed
1 Year 3 Months Ago on 1 Jun 2024
Mr Michael Dunn Appointed
1 Year 4 Months Ago on 29 Apr 2024
Cheryl Anne Moore Resigned
1 Year 4 Months Ago on 26 Apr 2024
Karen Chadwick Appointed
1 Year 5 Months Ago on 26 Mar 2024
Get Alerts
Get Credit Report
Discover Genome Research Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Confirmation statement made on 23 June 2025 with no updates
Submitted on 23 Jun 2025
Termination of appointment of Daniel Mahony as a director on 2 May 2025
Submitted on 12 May 2025
Full accounts made up to 30 September 2024
Submitted on 9 Jan 2025
Termination of appointment of Cilla Snowball as a director on 18 July 2024
Submitted on 30 Jul 2024
Confirmation statement made on 27 June 2024 with no updates
Submitted on 11 Jul 2024
Appointment of Dr John-Arne Røttingen as a director on 1 June 2024
Submitted on 10 Jun 2024
Termination of appointment of Paul Jakob Robert Schreier as a director on 1 June 2024
Submitted on 10 Jun 2024
Appointment of Mr Michael Dunn as a director on 29 April 2024
Submitted on 17 May 2024
Termination of appointment of Cheryl Anne Moore as a director on 26 April 2024
Submitted on 29 Apr 2024
Appointment of Karen Chadwick as a director on 26 March 2024
Submitted on 23 Apr 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs